CytomX Therapeutics, Inc. (CTMX)
NASDAQ: CTMX · IEX Real-Time Price · USD
2.250
+0.060 (2.74%)
Mar 28, 2024, 12:40 PM EDT - Market open

CytomX Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013
Revenue
101.2153.1637.3168.4326.959.571.6215.047.715.08
Upgrade
Revenue Growth (YoY)
90.38%42.48%-45.47%154.36%-54.79%-16.92%376.12%95.06%51.90%471.73%
Upgrade
Gross Profit
101.2153.1637.3168.4326.959.571.6215.047.715.08
Upgrade
Selling, General & Admin
30.0242.8539.1636.0336.7733.5125.6119.8712.566.54
Upgrade
Research & Development
77.68111.65114.19112.94131.62103.8792.2854.7628.3628.3
Upgrade
Operating Expenses
107.7154.5153.35148.97168.38137.38117.8874.6340.9234.84
Upgrade
Operating Income
-6.48-101.34-116.04-80.54-141.48-77.87-46.26-59.59-33.2-29.77
Upgrade
Interest Expense / Income
000000001.730.49
Upgrade
Other Expense / Income
-9.81-2.02-0.17-1.81-8.23-7.57-2.65-0.670.430.05
Upgrade
Pretax Income
3.32-99.32-115.87-78.73-133.25-70.3-43.61-58.92-35.36-30.3
Upgrade
Income Tax
3.8900-13.91-0.4314.3-0.51-0.020.010.01
Upgrade
Net Income
-0.57-99.32-115.87-64.82-132.83-84.6-43.1-58.9-35.37-30.31
Upgrade
Preferred Dividends
000000006.714.57
Upgrade
Net Income Common
-0.57-99.32-115.87-64.82-132.83-84.6-43.1-58.9-42.08-34.88
Upgrade
Shares Outstanding (Basic)
746664464542373691
Upgrade
Shares Outstanding (Diluted)
746664464542373691
Upgrade
Shares Change
12.27%2.48%39.01%1.79%8.81%12.10%2.57%321.57%768.69%28.11%
Upgrade
EPS (Basic)
-0.01-1.51-1.81-1.40-2.93-2.03-1.16-1.63-4.90-35.25
Upgrade
EPS (Diluted)
-0.01-1.51-1.81-1.40-2.93-2.03-1.16-1.63-4.90-35.25
Upgrade
Free Cash Flow
-56.88-112.53-120.642.95-143.98-79.31168.81-4.16-29.0130.14
Upgrade
Free Cash Flow Per Share
-0.77-1.71-1.880.06-3.18-1.904.54-0.12-3.3830.46
Upgrade
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%
Upgrade
Operating Margin
-6.41%-190.61%-311.00%-117.70%-525.92%-130.88%-64.59%-396.10%-430.54%-586.27%
Upgrade
Profit Margin
-0.56%-186.82%-310.54%-94.73%-493.74%-142.19%-60.17%-391.54%-545.63%-686.94%
Upgrade
Free Cash Flow Margin
-56.19%-211.67%-323.33%4.31%-535.19%-133.29%235.70%-27.63%-376.15%593.64%
Upgrade
Effective Tax Rate
117.12%---------
Upgrade
EBITDA
9.23-93.46-110.03-73.27-127.98-68.42-41.95-57.19-32.43-29.03
Upgrade
EBITDA Margin
9.12%-175.80%-294.89%-107.08%-475.71%-114.98%-58.57%-380.15%-420.46%-571.79%
Upgrade
Depreciation & Amortization
5.95.865.845.465.281.881.661.731.210.78
Upgrade
EBIT
3.32-99.32-115.87-78.73-133.25-70.3-43.61-58.92-33.63-29.81
Upgrade
EBIT Margin
3.28%-186.82%-310.54%-115.06%-495.32%-118.15%-60.89%-391.67%-436.10%-587.22%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).